cancer drugs

Graphic of two hands shaking under a red and purple light

Ratio, Ionetix ink separate radiopharmaceutical isotope deals

Ratio Therapeutics and Ionetix have each inked separate deals to boost the production of the key radiopharmaceutical isotope actinium-225.

Joseph Keenan Jun 23, 2025 11:08am

ranking gold star leader

AZ, Merck duke it out to lead oncologists’ pharma perceptions

May 22, 2025 10:54am

FDA conference hall

FDA to host first oncology adcomm meeting under Makary

May 8, 2025 11:35am

AstraZeneca inks $1.35B deal for subcutaneous cancer drugs

Mar 17, 2025 10:55am

Gavel with scales of justice in background

Roche settles UPenn patent lawsuit over breast cancer drugs

Mar 14, 2025 3:00pm

race cars race competition

Axplora to boost ADC production capacity at French facility

Mar 5, 2025 9:53am